Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (26025)
All Articles published online
|
Publishing Process of This Article
|
Jul 14, 2023 (publication date) through Oct 22, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Huang KY, Wang FY, Lv M, Ma XX, Tang XD, Lv L. Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment. World J Gastroenterol 2023; 29(26): 4120-4135 [PMID: 37475846 DOI: 10.3748/wjg.v29.i26.4120] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Huang KY, Wang FY, Lv M, Ma XX, Tang XD, Lv L. Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment. World J Gastroenterol 2023; 29(26): 4120-4135 [PMID: 37475846 DOI: 10.3748/wjg.v29.i26.4120] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i26/4120.htm |
| Number | Citing Articles |
| 1 |
Keren Hod, Giovanni Marasco, Luigi Colecchia, Cesare Cremon, Maria Raffaella Barbaro, Giulia Cacciari, Francesca Falangone, Anna Kagramanova, Dmitry Bordin, Vasile Drug, Egidia Miftode, Pietro Fusaroli, Salem Youssef Mohamed, Chiara Ricci, Massimo Bellini, M. Masudur Rahman, Luigi Melcarne, Javier Santos, Beatriz Lobo, Serhat Bor, Suna Yapali, Deniz Akyol, Ferdane Pirincci Sapmaz, Yonca Yilmaz Urun, Tugce Eskazan, Altay Celebi, Huseyin Kacmaz, Berat Ebik, Hatice Cilem Binicier, Mehmet Sait Bugdayci, Munkhtsetseg Banzragch Yağcı, Husnu Pullukcu, Berrin Yalınbas Kaya, Ali Tureyen, İbrahim Hatemi, Elif Sitre Koc, Goktug Sirin, Ali Riza Calıskan, Goksel Bengi, Esra Ergun Alıs, Snezana Lukic, Meri Trajkovska, Dan Dumitrascu, Antonello Pietrangelo, Elena Corradini, Magnus Simren, Jessica Sjolund, Navkiran Tornkvist, Uday C. Ghoshal, Olga Kolokolnikova, Antonio Colecchia, Jordi Serra, Giovanni Maconi, Roberto De Giorgio, Silvio Danese, Piero Portincasa, Antonio Di Sabatino, Marcello Maggio, Elena Philippou, Yeong Yeh Lee, Daniele Salvi, Alessandro Venturi, Claudio Borghi, Marco Zoli, Paolo Gionchetti, Pierluigi Viale, Vincenzo Stanghellini, Giovanni Barbara. Psychological and Clinical Factors Mediate Post‐COVID‐19 Irritable Bowel Syndrome. Neurogastroenterology & Motility 2025; doi: 10.1111/nmo.70079
|
| 2 |
Francisco Idalsoaga, Gustavo Ayares, Hanna Blaney, Daniel Cabrera, Javier Chahuan, Hugo Monrroy, Ayah Matar, Houssam Halawi, Marco Arrese, Juan Pablo Arab, Luis Antonio Díaz. Neurogastroenterology and motility disorders in patients with cirrhosis. Hepatology Communications 2025; 9(1) doi: 10.1097/HC9.0000000000000622
|
| 3 |
SUGAR-FREE, BUT NOT SYMPTOM-FREE: THE IMPACT OF ARTIFICIAL AND POLYOL-BASED SWEETENERS ON IBS AND GASTROINTESTINAL HEALTH. International Journal of Innovative Technologies in Social Science 2025; 2(3(47)) doi: 10.31435/ijitss.3(47).2025.3774
|
| 4 |
Lemonica Koumbi, Maria-Anna Giannelou, Lorys Castelli. The gut–brain axis in irritable bowel syndrome: neuroendocrine and epigenetic pathways. Academia Biology 2025; 3(2) doi: 10.20935/AcadBiol7748
|
| 5 |
Kingsley O Ozojide, Adaobi A Ozigbo, Kuukua K Ghartey , Okelue E Okobi, Nneka Muoghalu, Olabisi A Gbagba, Aminat D Lawal , Tinuola Andre (Fakoya), Simon Egyin, Faith C Anyanwu, Rukayat O Balogun. Demographic and Clinical Epidemiology of Irritable Bowel Syndrome in U.S. Community Health Centers: A Cross-Sectional Analysis of the 2022–2023 National Ambulatory Medical Care Survey. Cureus 2025; doi: 10.7759/cureus.87124
|
| 6 |
Alexander Bertuccioli, Davide Sisti, Nadia Lazzerini, Chiara Maria Palazzi, Giordano Bruno Zonzini, Mirko Ragazzini, Annalisa Belli. Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1604319
|
| 7 |
Sohel S. Shaikh, Sanjay Kumar. Role of Bacillus coagulans (Heyndrickxia coagulans)BCP92 in managing irritable bowel syndrome: A randomized, double-blind, multicenter, placebo-controlled clinical trial. Medicine 2024; 103(31): e39134 doi: 10.1097/MD.0000000000039134
|
| 8 |
Peicai Li, Yanping Tang, Lei Liu, Lei Yang, Li Yang, Zhongmei Sun, Yanxia Gong. The diagnostic criteria for psychosomatic research-revised (DCPR-R) in a National China multicenter cohort of patients with irritable bowel syndrome and overlapping gastroesophageal reflux disease. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03726-0
|
| 9 |
Alessandro Giammona, Bruno Giovanni Galuzzi, Elena Imperia, Clarissa Gervasoni, Sofia Remedia, Laura Restaneo, Martina Nespoli, Laura De Gara, Flaminia Tani, Michele Cicala, Michele Pier Luca Guarino, Danilo Porro, Antonio Cerasa, Alessia Lo Dico, Annamaria Altomare, Gloria Bertoli. Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date. International Journal of Molecular Sciences 2025; 26(1): 413 doi: 10.3390/ijms26010413
|
| 10 |
Alice Sandberg-Janzon, Pontus Karling. Prescription of commonly used drugs in patients with functional bowel disorders. A cross-sectional comparison with the general population. Scandinavian Journal of Gastroenterology 2025; 60(3): 253 doi: 10.1080/00365521.2025.2458070
|
| 11 |
Aleksandar Janev, Daša Zupančič, Peter Veranič, Tadeja Kuret. Oxidative Stress and Chronic Inflammation as Partners in Crime in Interstitial Cystitis/Bladder Pain Syndrome. Journal of Innate Immunity 2025; 17(1): 369 doi: 10.1159/000546901
|
| 12 |
Yuan Xia, Chang Liang, Hesheng Luo, Yan Zhang. Therapeutic Potential of Flavonoids and Flavonoid-Rich Compounds in Irritable Bowel Syndrome. Drug Design, Development and Therapy 2025; : 4895 doi: 10.2147/DDDT.S515004
|
| 13 |
Raquel Abalo, Paula Gallego-Barceló, Daniela Gabbia. Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies. International Journal of Molecular Sciences 2025; 26(19): 9345 doi: 10.3390/ijms26199345
|
| 14 |
Jiaoyan Yu, Xi Li, Yantao Sun, Ludan Wang, Yajun Zhang. Transcriptomic analysis and experiment to verify the mechanism of Xiaoyao san in the treatment of irritable bowel syndrome with depression. Journal of Ethnopharmacology 2025; 347: 119732 doi: 10.1016/j.jep.2025.119732
|
| 15 |
Jerlin Stephy JohnBritto, Agostino Di Ciaula, Antonino Noto, Velia Cassano, Angela Sciacqua, Mohamad Khalil, Piero Portincasa, Leonilde Bonfrate. Gender-specific insights into the irritable bowel syndrome pathophysiology. Focus on gut dysbiosis and permeability. European Journal of Internal Medicine 2024; 125: 10 doi: 10.1016/j.ejim.2024.03.011
|
| 16 |
Jean Carlos Fernando Besson, Isadora Carolina Rissi Colombo , Enrique Ayres de Oliveira, Nancy Christiane Ferreira Silva. SÍNDROME DO INTESTINO IRRITÁVEL NO CONTEXTO DE ESTRESSE CRÔNICO VIVENCIADO PELOS ESTUDANTES DE MEDICINA. Revista Contemporânea 2025; 5(3): e7748 doi: 10.56083/RCV5N3-078
|
| 17 |
Omid Vakili, Peyman Adibi Sedeh, Morteza Pourfarzam. Metabolic biomarkers in irritable bowel syndrome diagnosis. Clinica Chimica Acta 2024; 560: 119753 doi: 10.1016/j.cca.2024.119753
|
| 18 |
Silvia Molino, Lorenza Francesca De Lellis, Maria Vittoria Morone, Marcello Cordara, Danaè S. Larsen, Roberto Piccinocchi, Gaetano Piccinocchi, Alessandra Baldi, Alessandro Di Minno, Hesham R. El-Seedi, Roberto Sacchi, Maria Daglia. Improving Irritable Bowel Syndrome (IBS) Symptoms and Quality of Life with Quebracho and Chestnut Tannin-Based Supplementation: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients 2025; 17(3): 552 doi: 10.3390/nu17030552
|
| 19 |
Ronald L. Koretz. JPEN Journal Club 91. Choosing the population to study. Journal of Parenteral and Enteral Nutrition 2025; 49(6): 791 doi: 10.1002/jpen.2737
|
| 20 |
Binbin Tang, Ziwei Mei, Jun Chen, Guang Yu. Relationships Among Gut Microbiota, Plasma Inflammatory Cytokines, and Irritable Bowel Syndrome: A Mediation Mendelian Randomization Study. Neurogastroenterology & Motility 2025; doi: 10.1111/nmo.70178
|
| 21 |
Olga Biniszewska, Damian Jacenik, Aleksandra Tarasiuk, Jakub Fichna. Current and future pharmacotherapies for the management of constipation-predominant irritable bowel syndrome. Expert Opinion on Pharmacotherapy 2024; 25(8): 1039 doi: 10.1080/14656566.2024.2366993
|
| 22 |
Michael Cymbal, Arjun Chatterjee, Patricia Ajayi-Fox, Ruishen Lyu, Moises Auron, Brian B. Baggott. Specialty laboratory testing for chronic abdominal pain in irritable bowel syndrome. Scandinavian Journal of Gastroenterology 2025; 60(3): 248 doi: 10.1080/00365521.2025.2456491
|
| 23 |
Zhenyu Fan, Jiufang Yao, Xiayang Zeng, Jinhong Zuo, Jianpeng Qu. Investigation of the biomarkers and mechanism based on endoplasmic reticulum stress in irritable bowel syndrome. Arab Journal of Gastroenterology 2025; doi: 10.1016/j.ajg.2025.08.004
|
| 24 |
Hashim Mohamed Siraj, Mohammed Usaid, Saqib Shaikh, Mujahed Dalain, Yasmin Ansari, Samreen Zehra Naqvi, Raunak Hossain, Huda Anum, Catherine Andrews Ravi, Nivedita Pant, Mihir Awasarikar , Kainat Husain, Anushka Anand Hanchate, Aswija Sagam, Anand Balasubramanian . Bacterial Histamine as a Therapeutic Target for Abdominal Pain in Irritable Bowel Syndrome: A Literature Review. Cureus 2025; doi: 10.7759/cureus.82132
|
| 25 |
Ramón Saavedra-Bravo, Alfonso Méndez-Tenorio, Mario Angel López-Luis, Eduardo Alejandro Dávila-Martínez, Marco Antonio Vázquez-Ávila, Lenin García-Gutierrez, Gloria León-Avila, Cindy Bandala, Mónica Alethia Cureño-Díaz, Verónica Fernández-Sánchez, José Antonio Morales-González, Eleazar Lara-Padilla, Javier Mancilla-Ramírez, Gabriela Ibáñez-Cervantes. Description of the Distinctive Changes in the Colonic Microbiome Associated with Irritable Bowel Syndrome, Uncomplicated Diverticulitis, and Tubular Adenoma. Biomedicines 2025; 13(10): 2424 doi: 10.3390/biomedicines13102424
|
| 26 |
Yifan Xing, Lee Martin. Is there a sex difference in response to FODMAP diet group education for IBS? A clinical practice service evaluation. Nutrition and Health 2025; doi: 10.1177/02601060251324235
|
| 27 |
Dingfeng Chen. Combination therapy with otilonium bromide and trimebutine maleate demonstrates significant clinical advantages in irritable bowel syndrome patients. American Journal of Translational Research 2025; 17(6): 4859 doi: 10.62347/JFCI2618
|
| 28 |
I.Ya. Hospodarskyy, L.A. Hryshchuk, T.V. Boyko. The possibility of Bacillus probiotic use in patients with post-infectious irritable bowel syndrome after COVID-19 infection. GASTROENTEROLOGY 2024; 58(2): 121 doi: 10.22141/2308-2097.58.2.2024.605
|
| 29 |
C. Caranfil, G. Lorenzon, B. Barberio, R. Ramonda, E.V. Savarino, F. Zingone. Inflammatory bowel diseases and spondyloarthritis: a focus on female patients. Reumatismo 2024; 76(3) doi: 10.4081/reumatismo.2024.1770
|
| 30 |
THE EFFECTIVENESS OF PHARMACOLOGICAL, DIETARY, PSYCHOLOGICAL AND NOVEL TREATMENTS IN IRRITABLE BOWEL SYNDROME. International Journal of Innovative Technologies in Social Science 2025; 4(3(47)) doi: 10.31435/ijitss.3(47).2025.3739
|
| 31 |
Carolina Marques Lopes, Cristina Sofia de Jesus Monteiro, Ana Paula Duarte, Jorge Luiz dos Santos. Probiotics and Prebiotics for the Treatment of Irritable Bowel Syndrome—A Narrative Review. Journal of Clinical Medicine 2024; 13(21): 6337 doi: 10.3390/jcm13216337
|
| 32 |
Jiangbo Ying, Melvyn Weibin Zhang, Ker-Chiah Wei, Sunny H. Wong, Mythily Subramaniam. Influential articles in autism and gut microbiota: bibliometric profile and research trends. Frontiers in Microbiology 2025; 15 doi: 10.3389/fmicb.2024.1401597
|
| 33 |
Jun Zhao, Xia Li, Jiayi Yang, Xin Hao, Junjian Tian, Xin Wang, Xuefei Wang, Ning Li, Zhigang Li. Prevalence of and factors associated with symptoms consistent with a diagnosis of irritable bowel syndrome among resident physicians in standardised training in China: a cross-sectional study. BMJ Open 2023; 13(12): e079874 doi: 10.1136/bmjopen-2023-079874
|
| 34 |
J.A. Onofrijchuk , I.A. Svintsitskyi , G.A. Solovyova . Склад кишкового мікробіому й частота синдрому надмірного бактеріального росту в пацієнтів із синдромом подразненої кишки із закрепами та тиреоїдитом Хашимото з гіпотиреозом: пілотне одноцентрове крос-секційне дослідження. Endokrynologia 2024; 29(4): 324 doi: 10.31793/1680-1466.2024.29-4.324
|
| 35 |
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi. Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what’s new?. Expert Opinion on Drug Metabolism & Toxicology 2024; 20(5): 307 doi: 10.1080/17425255.2024.2348488
|
| 36 |
Yonghoon Choi, Young Hoon Youn, Seung Joo Kang, Jeong Eun Shin, Young Sin Cho, Yoon Suk Jung, Seung Yong Shin, Cheal Wung Huh, Yoo Jin Lee, Hoon Sup Koo, Kwangwoo Nam, Hong Sub Lee, Dong Hyun Kim, Ye Hyun Park, Min Cheol Kim, Hyo Yeop Song, Sung-Hoon Yoon, Sang Yeol Lee, Miyoung Choi, Moo-In Park, In-Kyung Sung. 2025 Seoul Consensus on Clinical Practice Guidelines for Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility 2025; 31(2): 133 doi: 10.5056/jnm25007
|
| 37 |
Aycan Gundogdu, Muzaffer Arikan, Alican Ulas, Seda Sevilay Koldaş, Gulfem Ece. From dysbiosis to therapy: Shared gut microbial signatures and targeted interventions across liver, heart and brain disorders. Next Research 2025; 2(4): 100846 doi: 10.1016/j.nexres.2025.100846
|
| 38 |
Jintao Fang, Weihan Zhu, Dian Yu, Lujian Zhu, Haorui Zha, Jingyi Tang, Yujia Li, Xiaxin Zhu, Ting Zhao, Wei Zhang. From Inflammasomes to Pyroptosis: Molecular Mechanisms in Chronic Intestinal Diseases — Opportunity or Challenge?. Journal of Inflammation Research 2025; : 3349 doi: 10.2147/JIR.S498703
|
| 39 |
Jiaotao Xing, Ying Li, Jiali Hu, Liyao Gu, Guanghua Sun, Xiangle Li. Lateral periaqueductal gray participate in the regulation of irritable bowel syndrome induced by chronic restraint stress. Neurobiology of Disease 2025; 204: 106758 doi: 10.1016/j.nbd.2024.106758
|
| 40 |
Francesco Pavan, Sunil Singh Yadav, Andrea Costantino, Alessandra Dell'Era, Monic Mastroianni, Massimiliano Buoli. The Effectiveness of Yoga for Irritable Bowel Syndrome: A Systematic Review. Comprehensive Physiology 2025; 15(5) doi: 10.1002/cph4.70061
|
| 41 |
Bernhard Uehleke, Martin Storr, Martin Hörning. Grapefruit Seed Extract Reduces Gastrointestinal
Symptoms. Zeitschrift für Phytotherapie 2024; 45(02): 54 doi: 10.1055/a-2194-2206
|
| 42 |
Mohammed Al-Beltagi, Nermin Kamal Saeed, Adel Salah Bediwy, Eman A Bediwy, Reem Elbeltagi. Unraveling functional neurological disorder in pediatric populations: A systematic review of diagnosis, treatment, and outcomes. World Journal of Clinical Pediatrics 2025; 14(3): 105290 doi: 10.5409/wjcp.v14.i3.105290
|
| 43 |
Weizi Wu, Jie Chen, Aolan Li, Ming-Hui Chen, Angela Starkweather, Xiaomei Cong. Mechanistic Insights into a Self-Management Intervention in Young Adults with Irritable Bowel Syndrome: A Pilot Multi-Omics Study. Biomedicines 2025; 13(9): 2102 doi: 10.3390/biomedicines13092102
|
| 44 |
Mohammed Al-Beltagi, Nermin K Saeed, Adel S Bediwy, Reem Elbeltagi. Breaking the cycle: Psychological and social dimensions of pediatric functional gastrointestinal disorders. World Journal of Clinical Pediatrics 2025; 14(2): 103323 doi: 10.5409/wjcp.v14.i2.103323
|
| 45 |
Michele Linsalata, Laura Prospero, Antonia Ignazzi, Giuseppe Riezzo, Benedetta D’Attoma, Domenica Mallardi, Francesco Goscilo, Maria Notarnicola, Valentina De Nunzio, Giuliano Pinto, Francesco Russo. Depression in Diarrhea-Predominant IBS Patients: Exploring the Link Between Gut Barrier Dysfunction and Erythrocyte Polyunsaturated Fatty Acid Levels. Journal of Clinical Medicine 2025; 14(7): 2483 doi: 10.3390/jcm14072483
|
| 46 |
Ploutarchos Pastras, Ioanna Aggeletopoulou, Christos Triantos. Impact of Enteric Nervous Cells on Irritable Bowel Syndrome: Potential Treatment Options. Microorganisms 2024; 12(10): 2036 doi: 10.3390/microorganisms12102036
|
| 47 |
Kaiyue Huang, Mi Lv, Ting Zheng, Fengyun Wang, Xudong Tang, Lin Lv. Herbal placebo response in clinical trials on irritable bowel syndrome: a systematic review and meta-analysis. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1475366
|
| 48 |
Nazila Dardmeh, Ali A. Moazzami, Masoud Yavarmanesh, Maryam M. Matin, Hamid Noorbakhsh. Effect of probiotic administration of Bifidobacterium animalis subsp. lactisBB‐12 and Lactiplantibacillus plantarum ATCC 14917 on metabolic profiles in an IBS‐D rat model: a metabolomic analysis approach. Journal of the Science of Food and Agriculture 2025; doi: 10.1002/jsfa.70190
|
| 49 |
Christian Lambiase, Alessandra Rossi, Riccardo Morganti, Lorenzo Cancelli, Antonio Grosso, Riccardo Tedeschi, Francesco Rettura, Marta Mosca, Nicola de Bortoli, Massimo Bellini. Adapted Low-FODMAP Diet in IBS Patients with and without Fibromyalgia: Long-Term Adherence and Outcomes. Nutrients 2024; 16(19): 3419 doi: 10.3390/nu16193419
|
| 50 |
Na-Ri Choi, Seok-Jae Ko, Joo-Hyun Nam, Woo-Gyun Choi, Jong-Hwan Lee, Seung-Yeol Nah, Jae-Woo Park, Byung-Joo Kim. Study on the Therapeutic Effects and Mechanisms of Gintonin in Irritable Bowel Syndrome and Its Relationship with TRPV1, TRPV4, and NaV1.5. Pharmaceuticals 2024; 17(9): 1170 doi: 10.3390/ph17091170
|
| 51 |
Yu-hao Lu, Shu-yue Lei, Tao Yang, You-sheng Xu, Hong-lin Wang, Chun-lan Feng, Wei Tang. PDE4 inhibitor apremilast ameliorates TNBS-induced irritable bowel syndrome in mice by activating the Nrf-2 signaling pathway in enteric glial cells. Acta Pharmacologica Sinica 2025; doi: 10.1038/s41401-025-01649-w
|
| 52 |
Kimia Shahbazi, Maryam Jameshorani, Amir Mahmoodkhani, Seyedeh Neda Mousavi. Dietary Inflammatory and Glycemic Indices in Newly Diagnosed Irritable Bowel Syndrome Patients Compared to Healthy People: A Case-Control Study. Journal of Human Environment and Health Promotion 2025; 11(1): 19 doi: 10.61186/jhehp.11.1.19
|
| 53 |
Hongxiu Chen, Zhifang Xu, Honggang Zhao, Jiazhen Cao, Rui Wang, Jing He, Ru Nie, Jialin Jia, Shuting Yuan, Yonghong Li, Zhicheng Liu, Xinyu Zhang, Lijuan Ha, Xiaoru Xu, Tie Li. Global research states and trends of micro RNA in irritable bowel syndrome: a bibliometric analysis. Clinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01396-y
|
| 54 |
Athanasia Dimitriou, Ioanna Aggeletopoulou, Christos Triantos. Optimizing Nutritional Balance: Integrating the Mediterranean Diet into Low-FODMAP Nutrition. Microorganisms 2025; 13(9): 2085 doi: 10.3390/microorganisms13092085
|
| 55 |
Hyder Osman Mirghani. Imaging findings of irritable bowel syndrome patients, and the diagnostic value of irritable bowel syndrome: A systematic review. World Journal of Methodology 2025; 15(4): 99785 doi: 10.5662/wjm.v15.i4.99785
|
| 56 |
Qing Ma, Zhangyu Jiang, Zerong Zhang, Lizhu Sun, Tao Su, Zhongqiu Liu, Rong Zhang. Qizhiweitong granule alleviates diarrhea-predominant irritable bowel syndrome via inhibition of the IL-6/Src/STAT3 feedback loop. Journal of Ethnopharmacology 2025; : 120772 doi: 10.1016/j.jep.2025.120772
|
| 57 |
Mhd Bashir Almonajjed, Mahdi Wardeh, Abdallah Atlagh, Abdulrahman Ismaiel, Stefan-Lucian Popa, Flaviu Rusu, Dan L. Dumitrascu. Impact of Microbiota on Irritable Bowel Syndrome Pathogenesis and Management: A Narrative Review. Medicina 2025; 61(1): 109 doi: 10.3390/medicina61010109
|
| 58 |
Ravi Shankar, Alexander Wenjun Yip. Sentiment analysis and topic modeling of social media data to explore public discourse on irritable bowel syndrome. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-08599-7
|
| 59 |
Qiaoxia Wang, Xiaoxuan Liu, Dongxing Song, Qingqing Wang, Mengjiao Wu, Zhihao Zhu, Mingxuan Jin, Siqi Liu, Jian Zhang, Rufeng Wang. Exploring the mechanism and effective compounds of Changan Granule on diarrhea-predominant irritable bowel syndrome via regulating 5-hydroxytryptamine signaling pathway in brain-gut axis. Phytomedicine 2025; 136: 156350 doi: 10.1016/j.phymed.2024.156350
|
| 60 |
Richard G. Barr. Invited Commentary: Ancillary US of the Bowel for Improved Patient Care and Management. RadioGraphics 2025; 45(9) doi: 10.1148/rg.240256
|
| 61 |
Saeede Jafari Nasab, Parisa Hajihashemi, Awat Feizi, Hassan Shahoon, Alireza Ani, Hamidreza Roohafza, Peyman Adibi, Mohammdanhasan Entezari, Mohammad Bagherniya. Effects of Spirulina platensis supplementation on quality of life, severity of disease and serum total antioxidant capacity, malondialdehyde and zonulin in constipation-predominant irritable bowel syndrome: protocol for a randomised, double-blinded, placebo-controlled clinical trial from Iran. BMJ Open 2025; 15(4): e086521 doi: 10.1136/bmjopen-2024-086521
|
| 62 |
Alexey M. Osadchuk, Irina D. Loranskaya, Mikhail A. Osadchuk. Comorbid functional pathology in gastroenterology. Possibilities and prospects for drug treatment: A review. Consilium Medicum 2024; 25(12): 844 doi: 10.26442/20751753.2023.12.202529
|
| 63 |
Jie Liu, Chaolan Lv, Mengqing Yin, Mengtao Zhu, Bo Wang, Jiashuang Tian, Kenji Hashimoto, Yue Yu. Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation in Patients With Constipation-Predominant Irritable Bowel Syndrome: A Single-Center, Single-Blind, Randomized Controlled Trial. American Journal of Gastroenterology 2025; 120(9): 2139 doi: 10.14309/ajg.0000000000003257
|
| 64 |
Juliana Soares Severo, Alda Cássia Alves da Silva, Brenda Lois Barros dos Santos, Thiago Sousa Reinaldo, Aureliano Machado de Oliveira, Rodrigo Soares Pereira Lima, Francisco Leonardo Torres-Leal, Armênio Aguiar dos Santos, Moisés Tolentino Bento da Silva. Physical Exercise as a Therapeutic Approach in Gastrointestinal Diseases. Journal of Clinical Medicine 2025; 14(5): 1708 doi: 10.3390/jcm14051708
|
| 65 |
Sulaiman A Alshammari, Mohsen N Almutairi, Mohammad O Alomar, Ziyad M Alsherif, Faisal H Alsubaie, Abdulrahman I Almezaini. Overlap Between Gastroesophageal Reflux Disease and Irritable Bowel Syndrome and Its Impact on Quality of Life. Cureus 2023; doi: 10.7759/cureus.50840
|
| 66 |
Fatima Soufan, Abir Ghosson, Rayyan Jaber, Adel Ghandour, Olivier Uwishema. The Gut‐Brain Axis in Irritable Bowel Syndrome: Implementing the Role of Microbiota and Neuroimmune Interaction in Personalized Prevention—A Narrative Review. Health Science Reports 2025; 8(4) doi: 10.1002/hsr2.70660
|
| 67 |
Ophélie Uriot, Charlotte Deschamps, Julien Scanzi, Morgane Brun, Nicolas Kerckhove, Christian Dualé, Elora Fournier, Claude Durif, Sylvain Denis, Michel Dapoigny, Philippe Langella, Monique Alric, Lucie Etienne-Mesmin, Blanquet-Diot Stéphanie. Gut microbial dysbiosis associated to diarrheic irritable bowel syndrome can be efficiently simulated in the Mucosal ARtificial COLon (M-ARCOL). Bioengineered 2025; 16(1) doi: 10.1080/21655979.2025.2458362
|
| 68 |
Chao Wang, Tengxiao Wang, Yangfang Chen, Wumei Lie, Fei Shen. Ebastine in combination with low-dose antidepressants for refractory irritable bowel syndrome: A randomized controlled trial. Technology and Health Care 2025; doi: 10.1177/09287329251334289
|
| 69 |
Vlad Alexandru Ionescu, Gina Gheorghe, Teodor Florin Georgescu, Nicolae Bacalbasa, Florentina Gheorghe, Camelia Cristina Diaconu. The Latest Data Concerning the Etiology and Pathogenesis of Irritable Bowel Syndrome. Journal of Clinical Medicine 2024; 13(17): 5124 doi: 10.3390/jcm13175124
|
| 70 |
Mihaela Stoyanova, Vera Gledacheva, Stoyanka Nikolova. Gut–Brain–Microbiota Axis in Irritable Bowel Syndrome: A Narrative Review of Pathophysiology and Current Approaches. Applied Sciences 2025; 15(12): 6441 doi: 10.3390/app15126441
|
| 71 |
Liangjun Yang, Zheng Fang, Jiajie Zhu, Xiaofang Li, Bo Yang, Haiyan Liu, Feiyan Lou. The potential of Sijunzi decoction in the fight against gastrointestinal disorders: a review. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1464498
|
| 72 |
Elena Montenegro-Borbolla, Jeanine Wakim El-Khoury, Claire Bertelli, Alain Schoepfer, Benoît Guery, Tatiana Galperine. Resolution of long-term severe irritable bowel syndrome following fecal microbiota transplantation: A case report and microbiota analysis. Gut Microbes Reports 2025; 2(1) doi: 10.1080/29933935.2025.2487905
|
| 73 |
E. Fazeli Moghadam, M. Samadi, S. Mohammadi, H. Yarizadeh, A. Abbasnezhad. The Relationship of Dietary Nutrient Patterns and Irritable Bowel Syndrome: A Multicenter Case–Control Study. Food Science & Nutrition 2025; 13(8) doi: 10.1002/fsn3.70742
|
| 74 |
Francesco Monaco, Annarita Vignapiano, Martina D’Angelo, Fabiola Raffone, Valeria Di Stefano, Antonella Boccia, Anna Longobardi, Benedetta Di Gruttola, Michele Fornaro, Giulio Corrivetti, Iolanda Martino, Luca Steardo, Luca Steardo. Case Report: The intersection of psychiatry and medicine: diagnostic and ethical insights from case studies. Frontiers in Psychiatry 2025; 16 doi: 10.3389/fpsyt.2025.1576179
|
| 75 |
清辉 杜. Exploring Treatment Strategies for Irritable Bowel Syndrome Based on the Concept of “Lung Being Connected with Large Intestine”. Advances in Clinical Medicine 2024; 14(09): 131 doi: 10.12677/acm.2024.1492439
|
| 76 |
Kai-Yue Huang, Jia-Yan Hu, Mi Lv, Feng-Yun Wang, Xiang-Xue Ma, Xu-Dong Tang, Lin Lv. Cerebral cortex changes in FD, IBS, and GERD: A Mendelian randomization study. Journal of Affective Disorders 2025; 369: 1153 doi: 10.1016/j.jad.2024.10.057
|
| 77 |
Wei-Hao Chai, Yan Ma, Jia-Jia Li, Fei Guo, Yi-Zhan Wu, Jiang-Wei Liu. Immune cell signatures and causal association with irritable bowel syndrome: A mendelian randomization study. World Journal of Clinical Cases 2024; 12(17): 3094-3104 doi: 10.12998/wjcc.v12.i17.3094
Abstract(562) |
Core Tip(561) |
Full Article(HTML)(2163)
|
Full Article with Cover (PDF)-9912K(145)
|
Full Article (Word)-1350K(4)
|
Audio-684K(12)
|
Peer-Review Report-195K(87)
|
Answering Reviewers-104K(83)
|
Full Article (PDF)-9454K(149)
|
Full Article (XML)-117K(93)
|
Times Cited (2)
|
Total Visits (6930)
|
Open
|
| 78 |
Michele Linsalata, Antonia Ignazzi, Benedetta D’Attoma, Giuseppe Riezzo, Domenica Mallardi, Antonella Orlando, Laura Prospero, Maria Notarnicola, Valentina De Nunzio, Giuliano Pinto, Francesco Russo. Relationship between Markers of Gut Barrier Function and Erythrocyte Membrane PUFAs in Diarrhea-Predominant IBS Patients Undergoing a Low-FODMAP Diet. Nutrients 2024; 16(16): 2706 doi: 10.3390/nu16162706
|